GUANGZHOU,China,Feb. 14,2025-- News report from GDToday. A photo exhibition titled "Nihao,China! See You in Guangdong" was held in Orange County,California,from January 23 to February 12,sho
WUHU,China,Feb. 14,2025--The T1 series,a new member ofJETOUR brand with a lite off-road shape artfully blending sportiness and toughness,has been awarded the 2024 Red Dot Design Concept Award. By winn
HANGZHOU,China,Feb. 14,2025-- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK),the world\'s leading premium new energy vehicle group,today a
SINGAPORE,Feb. 14,2025-- ATxEnterprise (ATxE) 2025,a flagship event of Asia Tech x Singapore (ATxSG),returns for its fifth year,providing a strategic platform for enterprises,governments,and technolo
BEIJING,Feb. 14,2025--A news report by China.org.cn on China\'s AI application:  
SHENZHEN,China,Feb. 14,2025-- Kexing Biopharm Co.,Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) of GB05,Human Interferon α1b Inhalation Solution,
SEOUL,South Korea,Feb. 13,2025-- DAAN Biotherapeutics,a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies,has signed an exclusive licensing agreement w
SINGAPORE,Feb. 13,2025-- Mega Matrix Inc. (NYSE American: MPU)\'s globally leading short series streaming platform,FlexTV,has launched a romantic miniseries exploring love,responsibility,and redempti
XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM).
- The company reports KRW373.0 billion in net sales,KRW166.3 billion in operating profit,and KRW142.4 billion in net income,reflecting year-over-year increases of 16.7%,41.2%,and 45.8%,respectively
© OfficialAffairs
